The study evaluated the outcomes of liver resection in patients with metastatic anal squamous cell carcinoma (SCC) to the liver. Among the 21 patients undergoing liver resection and/or ablation, 95% had undergone the Nigro protocol for the primary tumor, with 57% experiencing a complete response. The median overall survival was 32.2 months, and the 5-year overall survival rate was 50%. The most common site of recurrence was the liver. Liver resection can be a beneficial treatment option for carefully selected patients with metastatic anal SCC.
Journal Article by Lo WM, Dogeas E (…) Geller DA et 7 al. in J Surg Oncol
© 2023 Wiley Periodicals LLC.